![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The application of patient-derived organoid in the research of lung cancer
Yin Li, Xinyu Gao, Chao Ni, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 503-519
Open Access | Times Cited: 23
Yin Li, Xinyu Gao, Chao Ni, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 503-519
Open Access | Times Cited: 23
Showing 23 citing articles:
Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 83
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 83
Biomimetic Scaffolds—A Novel Approach to Three Dimensional Cell Culture Techniques for Potential Implementation in Tissue Engineering
Tomasz Górnicki, Jakub Lambrinow, Afsaneh Golkar‐Narenji, et al.
Nanomaterials (2024) Vol. 14, Iss. 6, pp. 531-531
Open Access | Times Cited: 16
Tomasz Górnicki, Jakub Lambrinow, Afsaneh Golkar‐Narenji, et al.
Nanomaterials (2024) Vol. 14, Iss. 6, pp. 531-531
Open Access | Times Cited: 16
Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
Jiankang Jin, Katsuhiro Yoshimura, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4352-4352
Open Access | Times Cited: 33
Jiankang Jin, Katsuhiro Yoshimura, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4352-4352
Open Access | Times Cited: 33
Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access
Jiejing Kai, Xueling Liu, Meijia Wu, et al.
Personalized Medicine (2025), pp. 1-14
Open Access
Huachansu suppresses colorectal cancer via inhibiting PI3K/AKT and glycolysis signaling pathways: Systems biology and network pharmacology
Hongxuan YANG, Yixu Chen, Chun-Lan Dai, et al.
Journal of Ethnopharmacology (2025), pp. 119479-119479
Closed Access
Hongxuan YANG, Yixu Chen, Chun-Lan Dai, et al.
Journal of Ethnopharmacology (2025), pp. 119479-119479
Closed Access
Recent frontiers in biofabrication for respiratory tissue engineering
Amanda Zimmerling, Nuraina Anisa Dahlan, Yan Zhou, et al.
Bioprinting (2024) Vol. 40, pp. e00342-e00342
Open Access | Times Cited: 5
Amanda Zimmerling, Nuraina Anisa Dahlan, Yan Zhou, et al.
Bioprinting (2024) Vol. 40, pp. e00342-e00342
Open Access | Times Cited: 5
Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
Leqing Zhu, Jianhua Zhang, Quanwei Guo, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 10
Leqing Zhu, Jianhua Zhang, Quanwei Guo, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 10
Systems approach for congruence and selection of cancer models towards precision medicine
Jian Zou, Osama Shiraz Shah, Yu‐Chiao Chiu, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011754-e1011754
Open Access | Times Cited: 3
Jian Zou, Osama Shiraz Shah, Yu‐Chiao Chiu, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011754-e1011754
Open Access | Times Cited: 3
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research
Sicheng Yan, Yuxuan He, Yuehong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Sicheng Yan, Yuxuan He, Yuehong Zhu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
Hélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Hélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Applications of Organoids in Advancing Drug Discovery and Development
Indiwari Gopallawa, Charu Agrawal, Rayan Jawa, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2659-2667
Closed Access | Times Cited: 2
Indiwari Gopallawa, Charu Agrawal, Rayan Jawa, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2659-2667
Closed Access | Times Cited: 2
Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells
Qiyue Luan, Inés Pulido, Angelique Isagirre, et al.
Lab on a Chip (2024) Vol. 24, Iss. 7, pp. 2025-2038
Open Access | Times Cited: 1
Qiyue Luan, Inés Pulido, Angelique Isagirre, et al.
Lab on a Chip (2024) Vol. 24, Iss. 7, pp. 2025-2038
Open Access | Times Cited: 1
Applied models and molecular characteristics of small cell lung cancer
Gabriella Fűr, Kolos Nemes, Éva Magó, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
Gabriella Fűr, Kolos Nemes, Éva Magó, et al.
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 1
Use and application of organ-on-a-chip platforms in cancer research
Yifan Yu, Tingting Zhou, L.-L. Cao
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1163-1179
Open Access | Times Cited: 4
Yifan Yu, Tingting Zhou, L.-L. Cao
Journal of Cell Communication and Signaling (2023) Vol. 17, Iss. 4, pp. 1163-1179
Open Access | Times Cited: 4
Mathematical Modeling of Non-Small-Cell Lung Cancer Biology through the Experimental Data on Cell Composition and Growth of Patient-Derived Organoids
Rushan A. Sulimanov, К. Б. Кошелев, Vladimir Makarov, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2228-2228
Open Access | Times Cited: 3
Rushan A. Sulimanov, К. Б. Кошелев, Vladimir Makarov, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2228-2228
Open Access | Times Cited: 3
Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse
Aria Vaishnavi, Conan G. Kinsey, Martin McMahon
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 1, pp. a041385-a041385
Closed Access | Times Cited: 2
Aria Vaishnavi, Conan G. Kinsey, Martin McMahon
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 1, pp. a041385-a041385
Closed Access | Times Cited: 2
Mathematical Modeling of Non-small Cell Lung Cancer Biology Through the Experimental Data on Cell Composition and Growth of Patient-Derived Organoids
Rushan A. Sulimanov, К. Б. Кошелев, Vladimir Makarov, et al.
(2023)
Open Access | Times Cited: 2
Rushan A. Sulimanov, К. Б. Кошелев, Vladimir Makarov, et al.
(2023)
Open Access | Times Cited: 2
3D cell culture models in research: applications to lung cancer pharmacology
Nathan Vella, Anthony G. Fenech, Vanessa Petroni Magri
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Nathan Vella, Anthony G. Fenech, Vanessa Petroni Magri
Frontiers in Pharmacology (2024) Vol. 15
Open Access
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1
Hongxiang Li, Yin Li, Xiaoxiao Zheng, et al.
Oncogene (2024)
Open Access
Hongxiang Li, Yin Li, Xiaoxiao Zheng, et al.
Oncogene (2024)
Open Access
Construction methods and latest applications of kidney cancer organoids
Zhiqiang Li, Y. Nancy You, Bo Feng, et al.
Oncology Reviews (2024) Vol. 18
Open Access
Zhiqiang Li, Y. Nancy You, Bo Feng, et al.
Oncology Reviews (2024) Vol. 18
Open Access
The pros and cons of mechanical dissociation and enzymatic digestion in patient-derived organoid cultures for solid tumor
Jing Ren, Mengli Liu, Mingjie Rong, et al.
Cell organoid (Print) (2024)
Closed Access
Jing Ren, Mengli Liu, Mingjie Rong, et al.
Cell organoid (Print) (2024)
Closed Access
Redox regulation of cancer stem cells: Biology and therapeutic implications
Min Du, Jian Zhang, Max S. Wicha, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
Min Du, Jian Zhang, Max S. Wicha, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access
How far have we come in our efforts to apply personalized therapy for lung cancer at bedside?
Hyun Soo Kim, In Kyoung Kim, Saemi Lee, et al.
Molecular & Cellular Toxicology (2024)
Closed Access
Hyun Soo Kim, In Kyoung Kim, Saemi Lee, et al.
Molecular & Cellular Toxicology (2024)
Closed Access